A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial

The objective of the study is to measure the efficacy of ionic-iodine polymer complex [1] for clinical and radiological improvement in coronavirus disease 2019 (COVID-19) patients. The trial will be closed label, randomized and placebo-controlled with a 1:1:1:1 allocation ratio and superiority frame...

Full description

Saved in:

Bibliographic Details
Published in:	Current controlled trials in cardiovascular medicine Vol. 22; no. 1; pp. 127 - 3
Main Authors:	Ashraf, Sohaib, Ashraf, Shoaib, Ashraf, Moneeb, Imran, Muhammad Ahmad, Kalsoom, Larab, Siddiqui, Uzma Nasim, Farooq, Iqra, Ghufran, Muhammad, Khokhar, Romaisa Arshad, Akram, Muhammad Kiwan, Shahid, Iqra, Sohaib Ur Rehman, Muhammad, Akmal, Rutaba, Tahir, Arbaz, Zahid, Ayesha, Ashraf, Sidra, Rafique, Sundas, Matti, Nazish, Nadeem, Muhammad Faisal, Humayun, Ayesha, Malik, Amber, Saboor, Qazi Abdul, Ahmad, Ali, Ashraf, Muhammad, Izhar, Mateen
Format:	Journal Article
Language:	English
Published:	England BioMed Central Ltd 10-02-2021 BioMed Central BMC
Subjects:	Adult Capsules Coronaviruses COVID-19 COVID-19 - drug therapy COVID-19 - epidemiology COVID-19 - mortality Dosage and administration Female Humans Iodine Iodine Compounds - administration & dosage Iodine in the body Letter Male Oral Sprays Pakistan Pakistan - epidemiology Patient Admission Polymers - administration & dosage Protocol Randomised controlled trial Randomized Controlled Trials as Topic Reverse Transcriptase Polymerase Chain Reaction SARS-CoV-2 - genetics Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Testing Treatment Outcome Pakistan COVID-19 Pakistan Protocol Randomised controlled trial Iodine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!